Trials / Terminated
TerminatedNCT00385021
ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Southwestern Regional Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 86 Years
- Healthy volunteers
- Not accepted
Summary
To determine efficacy in the delivery of chronomodulated chemotherapy.
Detailed description
The purpose of this study is to determine if treatment with 5-Fluorouracil, leucovorin, oxaliplatin, and Avastin will cause colorectal tumor cells to shrink or disappear. The study will also determine the safety of these drugs when given together and the quality of life of the patients who are enrolled in the study. It is thought that these drugs will be better tolerated if they are chronomodulated, i.e., if they are given at certain times of day rather than as a continuous infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5-Fluorouracil, leucovorin, oxaliplatin, avastin |
Timeline
- Start date
- 2006-10-01
- Completion
- 2007-09-01
- First posted
- 2006-10-06
- Last updated
- 2007-11-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00385021. Inclusion in this directory is not an endorsement.